Valganciclovir
Valcyte (valganciclovir) is a small molecule pharmaceutical. Valganciclovir was first approved as Valcyte on 2001-03-29. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Valcyte's patent is valid until 2027-12-11 (FDA).
| Trade Name | Valcyte |
|---|---|
| Common Name | Valganciclovir |
| Indication | aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis |
| Drug Class | Antivirals: antivirals (acyclovir type) |
